Skip to main content
European Commission logo print header

First wearable sensor for real-time monitoring and optimisation of sport training

Project description

Next generation wearable device for athletes

Wearable health devices are an emerging technology changing the health monitoring approach. Enabling self-health tracking and proactive health management, athletes are also turning to wearable sensors to monitor their performance, injury and recovery time. The EU-funded Smart Tracker project is bringing to market the Caura pack – the first molecular tracker that measures lactate and glucose in real-time to reveal the body’s molecular signature. For athletes, it provides valuable training insights on how their body is performing to avoid exhaustion. Non-invasive, wireless and continuous glucose and lactate monitoring helps athletes identify which diet works best, and the optimum time to train. The Caura pack makes use of new microneedle technology, a cost-effective digital tracker plus sophisticated machine learning algorithms.


Wearable biosensor systems for fitness and health monitoring have become popular in the last years, however, there is no
wearable technology currently available for accurately monitor key biometrics that directly reflect one’s body performance
(i.e. glucose and lactate) with clinical precision. In turn, Caura project aims at providing the first molecular tracker which
unlocks anyone’s molecular signature. It will give instant and real-time feedback on lifestyle and health, while providing
unmatched training insights and effective dietary plans through non-invasive, wireless and continuous glucose and lactate
monitoring. The invention relies on their cutting-edge microneedle technology, a cost-effective digital tracker plus
sophisticated machine learning algorithms allowing accurate and real-time glucose and lactate measurements for the first
time on the individual’s skin and under free living conditions. Caura will result on added value for high-quality wearables,
improving athletic performance and sport medicine by enabling ubiquitous monitoring of those biometrics. Other valuable
novelties are its reduced cost and dimensions compared to the available options. These advantages make Caura a
disruptive solution with great potential for commercial success in the growing wearables market (€285B by 2022, CAGR
12.5%), representing a core source of growth for the company and consolidating the Company position in the bio-sensing
sector. The Company will conduct a feasibility study and a business plan analyzing the technical, commercial and financial
aspects required to ensure the market launch. Being glucose and lactate important vital parameters also involved in some of
the biggest health issues (e.g. diabetes, obesity etc.), Caura will transition from simple recreational tracker to life-changing
tool focusing on individual’s lifestyle and health, enabling for the necessary transformation towards a person-centred
preventive health care system.

Call for proposal


See other projects for this call

Sub call




Net EU contribution
€ 50 000,00
Flat 7 3 elverton street royal westminster lodge
SW1P 2QW London
United Kingdom

See on map


The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

London Inner London — West Westminster
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 21 429,00